![Jeffrey L. Blumer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey L. Blumer
Profile
Jeffrey L.
Blumer is a Director of Encelle, Inc. He is Chief for the Division of Pediatric Pharmacology and Critical Care of Rainbow Babies.
He is a Professor of Pediatrics and Pharmacology for Case Western Reserve University.
He is a Director of the Cleveland Poison Control Center.
He received an MD from Case Western Reserve University and a PhD in Pharmacology from Northwestern University.
Former positions of Jeffrey L. Blumer
Companies | Position | End |
---|---|---|
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | Director/Board Member | 2008-10-16 |
Training of Jeffrey L. Blumer
Case Western Reserve University | Graduate Degree |
Northwestern University | Doctorate Degree |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | Health Technology |
- Stock Market
- Insiders
- Jeffrey L. Blumer